Skip to main content
. 2021 Aug 2;12:704290. doi: 10.3389/fphys.2021.704290

TABLE 1.

Summary of innovative potential treatments for CPTII deficiency patients.

graphic file with name fphys-12-704290-i000.jpg graphic file with name fphys-12-704290-i001.jpg graphic file with name fphys-12-704290-i002.jpg
50–55% Carbohydrates
A higher carbohydrates consumption (> 70% of energy) was related with a significantly higher risk of all-cause mortality
Exercise suggested
Personalized exercise programs combining HIIT or MIIT (≤70% VO2 max) with RT should be encouraged. For beginners or unfit categories, MIIT may be preferred
Supplements to support muscle bioenergetics, adaptations and functions:
Creatine: 3–5 g/day for 3–4 weeks whey proteins: 20–25 g or EAAs: 10–12 g Vitamin D: 2,000–4,000 IU/day
25–30% Proteins
High quality protein sources are recommended to optimize muscle recovery and stimulate muscle protein synthesis
Exercise to avoid
Traditional endurance activities (e.g., running, cycling, swimming) (<65% VO2 max) should be avoided in most CPTII deficiency patients
Supplements to attenuate EIMD and related inflammation:
Omega-3: 1.8–3.0 g/day Beetroot juice: 125–500 mL/day Pomegranate juice: 60–120 mL/day of concentrated product Tart cherries juice: 60 mL/day of concentrated product
20% Fats
Considered the minimum fats intake to ensure adequacy for essential FAs and fat-soluble vitamins
Lifestyle to maintain
Physical inactivity should be discouraged
Supplements for pain management:
Curcumin: 150–2,000 mg/day Ginger: 2,000 mg/day